OTC Sanitizer Contaminations Drop In US As Auxiliary Manufacturers Stop Production
Executive Summary
"Fewer people are manufacturing the products ... That seems to be a sort of a natural reaction to I think the decreased consumer demand," says Donald Ashley, compliance chief in FDA’s drug center.
You may also be interested in...
US FDA Recommends Tests, Documentation To Show Benzene No Higher Than 2PPM In Drugs
CDER says guidance needed to help facilitate and expedite reformulating drug products which use carbomers manufactured with benzene, a human carcinogen, so that no more than 2 parts per million of the substance is present.
Tighter Testing New Normal For US OTC Sanitizer Firms Due To Contaminations During Pandemic
With higher demand a norm, OTC sanitizer firms should do the same with scrutiny of their supplies of alcohol and other ingredients. “The market itself will always be much higher than a pre-COVID level as it’s a consumer product that is going to be used on a more regular basis,” says Ed Wyszumiala, head of US Pharmacopeia’s verification program.
US FDA Testing Finds Consumer Health Market Problems, But It Can’t Test Entire Marketplace
CDER compliance office director Donald Ashley offers a cautionary note to temper expectations for the FDA’s enforcement in the supplement sector. “We continue to warn the public about products very often sold as dietary supplements that contain hidden drugs,” he says.